Predictors of New Cerebral Microbleeds in Patients with Antiplatelet Drug Therapy

We found several predictors of CMB after initiation of antiplatelet drug therapy. The results help to identify patients who need closer monitoring and thorough control of risk factors in order to lower the risk of new CMB and associated complications.